A phase IB trial of the oral MEK inhibitor trametinib (GSK1120212) in combination with everolimus in patients with advanced solid tumors
Titel:
A phase IB trial of the oral MEK inhibitor trametinib (GSK1120212) in combination with everolimus in patients with advanced solid tumors
Auteur:
Tolcher, A.W. Bendell, J.C. Papadopoulos, K.P. Burris III, H.A. Patnaik, A. Jones, S.F. Rasco, D. Cox, D.S. Durante, M. Bellew, K.M. Park, J. Le, N.T. Infante, J.R.